Yeah. Attention's all over the resources sector at the moment. This isn't going to get attention until some concrete news comes out from Lilly, FDA or ACR. The USD exposure and the fact there's no link to the weakening Aussie economy should be helping but it's not.
Is prescription data for the past month available?
Yet another study has found Testosterone therapy does not increase risk of cardiovascular problems. http://www.hcplive.com/articles/Tes...art-Attack-or-Stroke-in-Men-with-Hypogonadism
Add to My Watchlist
What is My Watchlist?
